Calidi Biotherapeutics, Inc. (CLDI) Gets NYSE American Equity Deficiency Notice

Calidi Biotherapeutics received an NYSE American notice for non-compliance with stockholders’ equity requirements and must submit a plan by Oct. 21, 2026 to regain compliance by Mar. 21, 2028, or face potential delisting.Material DetailsContext by AI AnalystThis is an early regulatory setback highl…